White paper

22 September 2020, Munich - Losartan API prices tripled in a very short period while it was considered as a potential CoViD-19 remedy earlier this year. Other related substances have fared rather stable throughout the crisis, and one well-known “sartan” never recovered from its NDMA scandal in 2018...

20 August 2020, Munich - Prices for penicillins increased by 14-20 % during the first half of 2020 with prices for some penicillin APIs “shooting up” more than 40 %. Governments worldwide have undertaken efforts to decrease reliance on API imports from Asia...

18 June 2020, Munich - British scientists from Oxford University published a study about Dexamethasone demonstrating positive effects on patients requiring ventilation due to a corona infection...

14 May 2020, Munich - Primarily driven by lower prices for APIs manufacturing has mainly moved to India and China. The corona crisis could become a turning point for the pharmaceutical industry...

29 April 2020, Munich - Shortly after the outbreak of the corona crisis, scientists started to test existing drugs as potential remedies. Two malaria drugs received particular attention and widespread media coverage...

22 March 2020, Munich - Remedies against HIV, Malaria or high blood pressure are under evaluation in the fight of COVID-19. If proven effective...